CSX: A Strong Player In A Changing Freight Market — Positive

CSX   Seeking Alpha — May 07, 2025

CSX Corporation, a key player in U.S. railroads, excels in logistics, focusing on efficiency, profitability, and reducing emissions under new CEO Joe Hinrichs. Despite revenue stagnation, CSX maintains high profitability through Precision Scheduled Railroading, cost optimization, and strategic investments in intermodal transport and infrastructure modernization. The company's shares are undervalued, trading at discounts compared to historical and peer averages, presenting a buying opportunity with a potential 16.31% price increase.

image for news CSX: A Strong Player In A Changing Freight Market

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of AvidXchange Holdings, Inc. (NASDAQ: AVDX) breached their fiduciary duties in connection with the proposed sale of the Company to TPG Inc. (NASDAQ: TPG).

image for news Johnson Fistel Investigates Fairness of Proposed Sale of AvidXchange Holdings to TPG Inc.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold market analysis for May 7 - key intra-day price entry levels for active traders

MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations related to Alterity's clinical programs in Multiple System Atrophy (MSA) will be featured at the 2025 International MSA Congress taking place May 9 - 11, 2025 in Boston, MA, USA. The Congress is presented by Mission MSA, a non-profit organization dedicated to improving the quality of life and building hope for people affected by MSA through support services, educational …

image for news Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

These 3 Rock Star Entertainment Stocks Are Dominating 2025 — Positive

RBLX  SPOT  TME   MarketBeat — May 07, 2025

The market has been treading through rough waters in 2025, but several stocks in the entertainment industry are among the stars shining the brightest despite this. While many sectors have struggled to gain traction amid economic uncertainty and mixed earnings results, a select group of entertainment names has managed to stand out.

image for news These 3 Rock Star Entertainment Stocks Are Dominating 2025

ENR Q2 Earnings Miss, FY25 Guidance Down, Stock Falls Nearly 8% — Negative

ENR   Zacks Investment Research — May 07, 2025

Energizer's fiscal second-quarter net sales and earnings decline year over year. The company lowers its fiscal 2025 guidance amid ongoing macroeconomic headwinds.

image for news ENR Q2 Earnings Miss, FY25 Guidance Down, Stock Falls Nearly 8%

Bull of the Day: Nomad Foods (NOMD) — Positive

NOMD   Zacks Investment Research — May 07, 2025

Yes, Consumer Staples are boring but nothing is boring about making money.

image for news Bull of the Day: Nomad Foods (NOMD)

Ares Commercial Real Estate (ACRE) Beats Q1 Earnings Estimates — Positive

ACRE   Zacks Investment Research — May 07, 2025

Ares Commercial Real Estate (ACRE) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.62 per share a year ago.

image for news Ares Commercial Real Estate (ACRE) Beats Q1 Earnings Estimates

Entegris (ENTG) Q1 Earnings and Revenues Lag Estimates — Negative

ENTG   Zacks Investment Research — May 07, 2025

Entegris (ENTG) came out with quarterly earnings of $0.67 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.68 per share a year ago.

image for news Entegris (ENTG) Q1 Earnings and Revenues Lag Estimates

National Vision (EYE) Beats Q1 Earnings and Revenue Estimates — Positive

EYE   Zacks Investment Research — May 07, 2025

National Vision (EYE) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.30 per share a year ago.

image for news National Vision (EYE) Beats Q1 Earnings and Revenue Estimates

Acushnet (GOLF) Q1 Earnings and Revenues Surpass Estimates — Positive

GOLF   Zacks Investment Research — May 07, 2025

Acushnet (GOLF) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.43 per share a year ago.

image for news Acushnet (GOLF) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates — Positive

LIVN   Zacks Investment Research — May 07, 2025

LivaNova (LIVN) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.73 per share a year ago.

image for news LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

Axalta Coating Systems (AXTA) Beats Q1 Earnings Estimates — Positive

AXTA   Zacks Investment Research — May 07, 2025

Axalta Coating Systems (AXTA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.48 per share a year ago.

image for news Axalta Coating Systems (AXTA) Beats Q1 Earnings Estimates

Radware (RDWR) Beats Q1 Earnings and Revenue Estimates — Positive

RDWR   Zacks Investment Research — May 07, 2025

Radware (RDWR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.16 per share a year ago.

image for news Radware (RDWR) Beats Q1 Earnings and Revenue Estimates

The New Recruiting Initiative has the Potential to Bring 525 Students from these Regions into Davis University over the Term of the Agreement MIDDLETOWN, Ohio , May 7, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced that on May 1, 2025, its owned and operated Davis University ("Davis") entered into an Agency Agreement (the "Agreement") with MSM Unify to drive student recruitment from Africa and the Middle East on behalf of Davis University. …

image for news EpicQuest Education Enters into Key Agreement as Catalyst for Recruiting from Africa and the Middle East

ENGLEWOOD, Colo.--(BUSINESS WIRE)--LIBERTY MEDIA CORPORATION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS.

image for news Liberty Media Corporation Reports First Quarter 2025 Financial Results

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=147265&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=147264&wire=1 or contact Joseph E. Levi, Esq.

image for news Ibotta, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - IBTA

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=147266&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Shareholders of Zenas BioPharma, Inc. (ZBIO) of a Class Action Lawsuit and an Upcoming Deadline

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close.

image for news STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update